Ra Capital Management, L.P. Iovance Biotherapeutics, Inc. Transaction History

Ra Capital Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$9.78 - $24.52 $25.5 Million - $64 Million	-2,610,510 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$8.41 - $11.26 $924,612 - $1.24 Million	-109,942 Reduced 4.04%	2,610,510 $24.8 Million
Q4 2018 Feb 14, 2019	BUY	$7.51 - $11.93 $12 Million - $19.1 Million	1,599,299 Added 142.65%	2,720,452 $24.1 Million
Q2 2018 Aug 14, 2018	BUY	$12.45 - $16.95 $5.75 Million - $7.83 Million	462,094 Added 70.11%	1,121,153 $14.4 Million
Q1 2018 May 15, 2018	BUY	$8.1 - $19.5 $5.34 Million - $12.9 Million	659,059 New	659,059 $11.1 Million

320

238M

1.27M

1.68M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.74B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Ra Capital Management, L.P. with notifications on news.